CDSCO is involved in the registration of medical devices, drugs and cosmetics in India. The Indian Pharmacopoeia Commission (IPC) is planning to extend across multiple cities. IPC will start its regional arm in the zonal and sub zonal regional offices of the Central Drugs Standard Control Organization (CDSCO). Chennai, Kolkata, Mumbai and Hyderabad are chosen as potential places to start with. Dr G N Singh, drug controller general of India (DCGI) informed IPC has already started setting up in Mumbai. Hopefully, IPC might start operations by the end of the year in Mumbai followed by Hyderabad, Chennai and Kolkata.
READ ALSO: Step by step process to register medical devices in CDSCO, Manufacturing License in India
CDSCO which is involved in registration of medical devices, drugs, cosmetics in India is actively working on different measures. “This will strengthen our commitment of setting standard body and support CDSCO on medicine regulation efficiently. To ensure best healthcare practices, steps are taken to expose PvPI programme and create an overall impact. It will also reduce the duplication of work and ensure we are same lines for drug safety issues in the country” Dr G N Singh added. Some strategic moves are also taken to increase the number of adverse drug reaction (ADR) monitoring centres (AMC) from 150 to 200 before this year.
Other News
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
